文献速递眼底病与葡萄膜炎

EyeArt 基于眼底图像检测糖尿病视网膜病变的诊断准确性:一项系统综述与荟萃分析

Diagnostic Accuracy of EyeArt for Fundus-Based Detection of Diabetic Retinopathy: A Systematic Review and Meta-analysis.
PubMed 文献 · Am J Ophthalmol · 2025-10-04

该系统综述与荟萃分析纳入17项研究共162,695次检查,评估EyeArt从彩色眼底照片检测需转诊糖尿病视网膜病变(rDR)的准确性,合并敏感度为95%(95%CI 92%-97%),特异度为81%(95%CI 74%-87%);敏感度证据确定性高、特异度中等,特异度变异及不可分级图像报告/处理不一致需关注。

要点

  • EyeArt检测rDR合并敏感度95%(95%CI 92%-97%),特异度81%(95%CI 74%-87%)。
  • 敏感度证据确定性高,特异度证据确定性中等。
  • 特异度随厂商参与略有变异,不可分级图像报告与处理不一致需标准化质控。

核心结论

  • 17项真实世界研究(162,695次检查)显示EyeArt检测需转诊糖尿病视网膜病变诊断准确性高,合并敏感度95%、特异度81%。
  • 敏感度证据确定性高、特异度证据确定性中等,持续强敏感度支持在初级保健中自主筛查。
  • 特异度变异及不可分级图像报告/处理不一致需关注并标准化质量保证。

研究设计与样本

  • 遵循PRISMA-DTA指南的系统综述与荟萃分析,检索PubMed、Embase和ClinicalTrials.gov至2025年4月。
  • 纳入采用EyeArt筛查的成年人群研究,共17项研究、162,695次检查。
  • 采用双变量随机效应模型合并敏感度与特异度,并行亚组与适用性分析评估异质性与临床相关性。

主要发现

  • EyeArt检测需转诊糖尿病视网膜病变的合并敏感度为95%(95%CI 92%-97%),合并特异度为81%(95%CI 74%-87%)。
  • 亚组分析显示在不同研究设计、经济环境、医疗背景、设备类型、外部验证和图像可分级性方面准确性一致。
  • 特异度随厂商参与略有变异。

关键数值与推荐

  • 合并敏感度95%(95%CI 92%-97%),合并特异度81%(95%CI 74%-87%),对象为接受EyeArt筛查的成年人群。

临床怎么用

  • 持续强敏感度支持在初级保健中开展自主筛查(原文结论)。
  • 成功部署取决于工作流程/电子健康记录整合、可持续报销及在服务不足人群中针对性实施(原文结论)。
  • 原文指出不可分级图像报告/处理不一致需关注并标准化质量保证(原文结论)。

局限性

  • 特异度存在变异。
  • 不可分级图像的报告与处理不一致,需关注并标准化质量保证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Diabetic retinopathy (DR) is a leading cause of preventable blindness globally. Although early detection via routine retinal screening significantly reduces vision loss, screening rates remain suboptimal due to workforce shortages and limited accessibility. Autonomous artificial intelligence (AI) systems such as EyeArt offer an FDA-authorized solution for point-of-care DR screening without ophthalmologist oversight METHODS: We conducted a systematic review and meta-analysis following PRISMA-DTA guidelines to assess the diagnostic accuracy of EyeArt in detecting referable diabetic retinopathy (rDR) from color fundus photographs. Searches of PubMed, Embase, and ClinicalTrials.gov through April 2025 identified eligible studies involving adult populations screened with EyeArt. Sensitivity and specificity were pooled using bivariate random-effects models. Subgroup and applicability analyses were conducted to evaluate heterogeneity and clinical relevance. RESULTS: Seventeen studies comprising 162,695 examinations were included. EyeArt demonstrated a pooled sensitivity of 95% (95% CI: 92%-97%) and specificity of 81% (95% CI: 74%-87%). Subgroup analyses indicated consistent accuracy across study designs, economic settings, healthcare contexts, device types, external validation, and image gradability. Specificity varied slightly with vendor involvement. CONCLUSIONS: Across 17 real-world studies (162,695 examinations), EyeArt exhibits high diagnostic accuracy for detecting referable diabetic retinopathy (pooled sensitivity 95%, specificity 81%), with high certainty for sensitivity and moderate certainty for specificity. Its consistently strong sensitivity supports autonomous screening in primary care. However, variability in specificity-along with inconsistent reporting/handling of ungradable images-warrants attention and standardized quality-assurance. Successful deployment will depend on workflow/EHR integration, sustainable reimbursement, and targeted implementation in underserved populations to maximize public-health impact.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Wang TW, Luo WT, Tu YK, et al. Diagnostic Accuracy of EyeArt for Fundus-Based Detection of Diabetic Retinopathy: A Systematic Review and Meta-analysis. Am J Ophthalmol. 2025. PMID: 41052568. doi:10.1016/j.ajo.2025.09.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。